MMP-1(-1607G) polymorphism as a risk factor for fi brosis after pulmonary tuberculosis in Taiwan

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 5, 2010, Pages 627-634

  Wang, C H ^a,b   Lin, H C ^a,b   Lin, S M ^a   Huang, C D ^a   Liu, C Y ^a   Huang, K H ^a   Hsieh, L L ^c   Chung, K F ^d   Kuo, H P ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Department of Chinese Medicine ^*  (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Genetic polymorphisms; Lung fi brosis; Matrix metalloproteinase 1; Matrix metalloproteinase 12; Tuberculosis

Indexed keywords

ETHAMBUTOL; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ALLELE; ARTICLE; CELL STIMULATION; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LUNG FIBROSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TAIWAN; THORAX RADIOGRAPHY;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 77950870329     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hatipoglu O N, Osma E, Manisali M, et al. High resolution computed tomographic f ndings in pulmonary tuberculosis. Thorax 1996; 51: 397-402. (Pubitemid 26140205)
2. Long R, Maycher B, Dhar A, et al. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest 1998; 113: 933-943. (Pubitemid 28216435)
3. Friedland J S, Shaw T C, Price N M, et al. Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis. Matrix Biol 2002; 21: 103-110.
4. Campbell E J, Cury J D, Shapiro S D, et al. Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metallo-proteinases, and tissue inhibitor of metalloproteinases. J I mmunol 1991; 146: 1286-1293.
5. Zhang Y, McCluskey K, Fujii K, et al. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and-independent mechanisms. J Immunol 1998; 161: 3071-3076. (Pubitemid 28425734)
6. Saren P, Welgus H G, Kovanen P T. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996; 157: 4159-4165. (Pubitemid 126449330)
7. Price N M, Gilman R H, Uddin J, et al. Unopposed matrix metalloproteinase-9 expression in human tuberculous granu-loma and the role of TNF-alpha-dependent monocyte networks. J Immunol 2003; 171: 5579-5586. (Pubitemid 37432849)
8. Quiding-Jarbrink M, Smith D A, Bancroft G J. Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun 2001; 69: 5661-5670. (Pubitemid 32786504)
9. Hoheisel G, Sack U, Hui D S, et al. Occurrence of matrix me-talloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb) 2001; 81: 203-209. (Pubitemid 32575228)
10. Elkington P T, Emerson J E, Lopez-Pascua L D, et al. Mycobac-terium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch. J Immunol 2005; 175: 5333-5340.
11. Ninomiya S, Niimi T, Shimizu S, et al. Matrix metallo-proteinase-1 polymorphism of promoter region in sarcoidosis and tuberculosis patients. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 19-24. (Pubitemid 38533809)
12. Kuo H P, Wang Y M, Wang C H, et al. Matrix metallo-proteinase-1 polymorphism in Taiwanese patients with endo-bronchial tuberculosis. Tuberculosis (Edinb) 2008; 88: 262-267.
13. Henry M T, McMahon K, Mackarel A J, et al. Matrix metallo-proteinases and tissue inhibitor of metalloproteinase-1 in sar-coidosis and IPF. Eur Respir J 2002; 20: 1220-1227. (Pubitemid 35331881)
14. Joos L, He J Q, Shepherdson M B, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002; 11: 569-576. (Pubitemid 34257493)
15. Kanamori Y, Matsushima M, Minaguchi T, et al. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999; 59: 4225-4227. (Pubitemid 29418732)
16. Minematsu N, Nakamura H, Tateno H, et al. Genetic polymorphism in matrix metalloproteinase-9 and pulmonary emphysema. Biochem Biophys Res Commun 2001; 289: 116-119. (Pubitemid 33108801)
17. Wang C H, Liu C Y, Lin H C, et al. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998; 11: 809-815.
18. Simon G. Radiography in epidemiological studies and some therapeutic trials. BMJ 1966; 2: 491-494.
19. Dunsmore S E, Rannels D E. Extracellular matrix biology in the lung. Am J Physiol 1996; 270: L3-L27. (Pubitemid 26057327)
20. Zuo F, Kaminski N, Eugui E, et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary f brosis in mice and humans. Proc Natl Acad Sci USA 2002; 99: 6292-6297. (Pubitemid 34493305)
21. Selman M, Ruiz V, Cabrera S, et al. TIMP-1,-2,-3, and-4 in idiopathic pulmonary f brosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 2000; 279: L562-574.
22. Rutter J L, Mitchell T I, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998; 58: 5321-5325. (Pubitemid 28551108)
23. Tower G B, Coon C C, Benbow U, et al. Erk 1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells. Biochim Biophys Acta 2002; 1586: 265-274. (Pubitemid 34457921)
24. Zhu Y, Spitz M R, Lei L, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001; 61: 7825-7829. (Pubitemid 33049371)
25. Ghilardi G, Biondi M L, Mangoni J, et al. Matrix metallo-proteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001; 7: 2344-2346. (Pubitemid 32751634)
26. Vairaktaris E, Yapijakis C, Derka S, et al. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma. Anticancer Res 2007; 27: 459-464. (Pubitemid 46363366)
27. Benbow U, Tower G B, Wyatt C A, et al. High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells. J Cell Biochem 2002; 86: 307-319. (Pubitemid 34743387)
28. Eickelberg O, Kohler E, Reichenberger F, et al. Extracellular matrix deposition by primary human lung f broblasts in response to TGF-beta1 and TGF-beta3. Am J Physiol 1999; 276: L814-L824. (Pubitemid 29249635)
29. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell Biol 2005; 37: 283-288. (Pubitemid 39330190)
30. Fiorenza G, Rateni L, Farroni M A, et al. TNF-alpha, TGF-beta and NO relationship in sera from tuberculosis (TB) patients of different severity. Immunol Lett 2005; 98: 45-48. (Pubitemid 40409817)
31. Agarwal A R, Mih J, George S C. Expression of matrix proteins in an in vitro model of airway remodeling in asthma. Allergy Asthma Proc 2003; 24: 35-42. (Pubitemid 37034206)
32. Fineschi S, Reith W, Guerne P A, et al. Proteasome blockade exerts an antif brotic activity by coordinately down-regulating type I collagen and tissue inhibitor of metalloproteinase-1 and up-regulating metalloproteinase-1 production in human dermal f broblasts. FASEB J 2006; 20: 562-564. (Pubitemid 46671250)
33. Yamamoto T, Eckes B, Mauch C, et al. Monocyte chemoattrac-tant protein-1 enhances gene expression and synthesis of matrix metalloproteinase-1 in human f broblasts by an autocrine IL-1 alpha loop. J Immunol 2000; 164: 6174-6179. (Pubitemid 30408794)
34. Hrabec E, Strek M, Zieba M, et al. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 2002; 6: 713-719. (Pubitemid 34832152)
35. Hautamaki R D, Kobayashi D K, Senior R M, et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277: 2002-2004.
36. Fukuda Y, Ishizaki M, Kudoh S, et al. Localization of matrix metalloproteinases-1,-2, and-9 and tissue inhibitor of metallo-proteinase-2 in interstitial lung diseases. Lab Invest 1998; 78: 687-698. (Pubitemid 28307326)